86 results
Page 2 of 5
S-8
lqf30mcyj fy8a3zz
28 Feb 22
Registration of securities for employees
4:51pm
424B5
05cigep 9j
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
hlf9xi3h
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
sxo6ov15os
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
j4kfh2ae
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.3
13p4tudyd2b lxvchoh7
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
S-8
osttev3ftgdos3
1 Mar 21
Registration of securities for employees
12:00am
8-K
EX-1.1
yr3wxhxi91iuz594s
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
q9u3asyaiou3m p7
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
by2 ks2atz7a
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
EX-4.5
xlz4yvauvzcy ed
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
s1qgqzpl4t4n2f
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.6
d55dzvxneum
14 Dec 20
Automatic shelf registration
4:02pm